Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia Journal Article

   

Authors:	Ravandi, F.; Ritchie, E. K.; Sayar, H.; Lancet, J. E.; Craig, M. D.; Vey, N.; Strickland, S. A.; Schiller, G. J.; Jabbour, E.; Pigneux, A.; Horst, H. A.; Récher, C.; Klimek, V. M.; Cortes, J. E.; Carella, A. M.; Egyed, M.; Krug, U.; Fox, J. A.; Craig, A. R.; Ward, R.; Smith, J. A.; Acton, G.; Kantarjian, H. M.; Stuart, R. K.
Article Title:	Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia
Journal Title:	Haematologica
Volume:	103
Issue:	11
ISSN:	0390-6078
Publisher:	Ferrata Storti Foundation
Date Published:	2018-11-01
Start Page:	e514
End Page:	e518
Language:	English
DOI:	10.3324/haematol.2018.191361
PUBMED:	29794146
PROVIDER:	scopus
PMCID:	PMC6278965
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85055851886&doi=10.3324%2fhaematol.2018.191361&partnerID=40&md5=122d076f1e6ff4c84abaa1e6e7905076
Notes:	Letter -- Export Date: 3 December 2018 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/134780